Share this post on:

Product Name :
RGT-691

Search keywords :
Protein-arginine deiminase

drugId :
null

Target Vo:
Protein-arginine deiminase type-4

Target Vo Short Name :
PADI4

Moa_Name:
Protein-arginine deiminase type-4 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Regor Therapeutics Group

Active Company_Name :
Regor Therapeutics Group

Active Indication_Name:
Inflammation

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:
Preclinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Integrin beta 1 Antibody
Phospho-FOXO3a(Ser253) Antibody
Nanog Antibody: Nanog Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 35 kDa, targeting to Nanog. It can be used for WB,ICC/IF,FC,IHC-P assays with tag free, in the background of Human, Mouse.

Share this post on:

Author: Interleukin Related